Table 1 Baseline Clinical Characteristics (n=63) Table 1 Baseline Clinical Characteristics (n=63)
Age (yrs) 60.3 ± 11.4
Male 38 (60.3)
LVEF (%) 59.3 ± 7.5
LA diameter (mm) 4.4 ± 0.6
Height (cm) 173.8 ± 11.7
Weight (kg) 91.3 ± 17.5
Resting Heart Rate (bpm) 72.2 ± 17.6
Resting Systolic Blood Pressure (mmHg) 142.5 ± 17.6
Resting Diastolic Blood Pressure (mmHg) 82.6 ± 10.1
Hemoglobin (g/l) 140 ± 33.5
Creatinine (µmol/l) 88.5 ± 17.8
Glomerular Filtration Rate (ml/min/1.73m2) 77.1 ± 19
AF duration (months) 40.5 ± 34.6
Hypertension 45 (71.4)
Heart failure 2 (3.2)
Diabetes mellitus 7 (11.1)
Stroke 5 (7.9)
CAD 6 (9.5)
CHA2DS2-VASc 1,8 ± 1,2
Antiarrhythmic Therapy
Class I 33 (52.4)
Class II 26 (41.3)
Class III 14 (22.2)
Class IV 0 (0)
Anticoagulation/Antiagregation Therapy
Vitamin K Antagonist 17 (27)
Direct Oral Anticoagulants 36 (57.1)
Acetylsalicylic Acid 4 (6.4)
Values are mean ± SD or n (%); AF = atrial fibrillation; CAD = coronary artery disease; LA = left atrial; LVEF = left ventricular ejection fraction. Values are mean ± SD or n (%); AF = atrial fibrillation; CAD = coronary artery disease; LA = left atrial; LVEF = left ventricular ejection fraction.